<?xml version='1.0' encoding='utf-8'?>
<document id="32201314"><sentence text="Apical sodium-dependent bile acid transporter, drug target for bile acid related diseases and delivery target for prodrugs: Current and future challenges."><entity charOffset="7-13" id="DDI-PubMed.32201314.s1.e0" text="sodium" /><entity charOffset="63-72" id="DDI-PubMed.32201314.s1.e1" text="bile acid" /><pair ddi="false" e1="DDI-PubMed.32201314.s1.e0" e2="DDI-PubMed.32201314.s1.e0" /><pair ddi="false" e1="DDI-PubMed.32201314.s1.e0" e2="DDI-PubMed.32201314.s1.e1" /></sentence><sentence text="Apical Sodium-dependent Bile Acid Transporter (ASBT) actively reabsorbs bile acids (BAs) from the gut lumen" /><sentence text=" This process is a critical step in the enterohepatic circulation (EHC) of BAs and plays important roles in the homeostasis of BAs in the body" /><sentence text=" Therefore, ASBT is considered a favorite target for intervention to regulate the levels of BAs, cholesterol, lipid and glucose etc"><entity charOffset="92-95" id="DDI-PubMed.32201314.s4.e0" text="BAs" /><entity charOffset="97-108" id="DDI-PubMed.32201314.s4.e1" text="cholesterol" /><entity charOffset="120-127" id="DDI-PubMed.32201314.s4.e2" text="glucose" /><pair ddi="false" e1="DDI-PubMed.32201314.s4.e0" e2="DDI-PubMed.32201314.s4.e0" /><pair ddi="false" e1="DDI-PubMed.32201314.s4.e0" e2="DDI-PubMed.32201314.s4.e1" /><pair ddi="false" e1="DDI-PubMed.32201314.s4.e0" e2="DDI-PubMed.32201314.s4.e2" /><pair ddi="false" e1="DDI-PubMed.32201314.s4.e1" e2="DDI-PubMed.32201314.s4.e1" /><pair ddi="false" e1="DDI-PubMed.32201314.s4.e1" e2="DDI-PubMed.32201314.s4.e2" /></sentence><sentence text=" In addition, ASBT is also a popular delivery target for developing prodrugs, due to its intestinal localization, high expression and high uptake capacity" /><sentence text=" In the past ten years, ASBT has been the focus by both academia and pharmaceutical industry as research targets not only for BA-related diseases but also for prodrug delivery" /><sentence text=" Numerous studies have been published and many candidate ASBT inhibitors are being developed" /><sentence text=" Here we review and summarize the current states of ASBT research with a focus on the therapeutic applications of ASBT as a target for therapy as well as a delivery target for prodrugs" /><sentence text=" The current and future challenges in ASBT research and outlook of drug developments are discussed" /><sentence text="" /></document>